Atlas Trials

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Clinical trial NCT06119256 · RECRUITING

Trial details

NCT number
NCT06119256
Sponsor
Chinese PLA General Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
EBV Infection After Allogenic HSCT
Start date
2023-08-01
Primary completion
2027-12-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.